Neuro.Capital

NeuroCapital Fund was founded with a bold mission: to invest in pioneering neurotechnology companies at the forefront of transforming how we understand and treat neurological conditions. Our focus extends across a diverse range of fields, including brain-machine interfaces (BMIs), neurodiagnostics, neurotherapeutics, cognitive enhancement technologies, and neuroprosthetics. These technologies are poised to not only address some of the most urgent healthcare challenges - such as Alzheimer's, Parkinson's, epilepsy, and other neurological disorders - but also to enhance human performance in areas like high-performance sports and cognitive optimization. By empowering groundbreaking innovations, we aim to create meaningful, scalable solutions with global impact.